|
|
||||||||
1 Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, RE 213B, 330 Brookline Avenue, Boston, MA 02215, USA
2 Institute of Genetics, University of Nottingham, Queens Medical Centre, Nottingham, UK
3 Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, RE 213B, 330 Brookline Avenue, Boston, MA 02215, USA
4 Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, RE 213B, 330 Brookline Avenue, Boston, MA 02215, USA
Correspondence
Igor J. Koralnik
ikoralni{at}bidmc.harvard.edu
To determine the variability of BK virus (BKV) in vivo, the sequences of nine full-length molecular clones from the striated muscle and heart DNA of a patient with BKV-associated capillary leak syndrome (BKVCAP), as well as three clones each from the urine of one human immunodeficiency virus type 2-positive (BKVHI) and one healthy control subject (BKVHC), were analysed. The regulatory region of all clones corresponded to the archetypal regulatory region usually found in urine isolates. Analysis of the predicted conformation of BKVCAP proteins did not suggest any structural differences on the surface of the viral particles compared with BKVHI and BKVHC clones. No amino acid changes common to most BKVCAP clones could be identified that have not already been reported in non-vasculotropic strains. However, the coding region of each clone had unique nucleotide substitutions, and intra-host variability was greater among BKVCAP clones, with a mean difference of 0·29 % per site compared with 0·16 % for BKVHI and 0·14 % for BKVHC. The clones from each strain formed monophyletic clades, suggesting a single source of infection for each subject. The most divergent BKVCAP clones differed at 0·55 % of sites, implying a rate of nucleotide substitution of approximately 5x105 substitutions per site per year, which is two orders of magnitude faster than estimated for the other human polyomavirus, JC virus.
The GenBank/EMBL/DDBJ accession numbers for the nucleotide sequences determined in this work are AY628224AY628238.
This article has been cited by other articles:
![]() |
N. G. Hoffman, L. Cook, E. E. Atienza, A. P. Limaye, and K. R. Jerome Marked Variability of BK Virus Load Measurement Using Quantitative Real-Time PCR among Commonly Used Assays J. Clin. Microbiol., August 1, 2008; 46(8): 2671 - 2680. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ikegaya, P. J. Saukko, R. Tertti, K. P. Metsarinne, M. J. Carr, B. Crowley, K. Sakurada, H.-Y. Zheng, T. Kitamura, and Y. Yogo Identification of a genomic subgroup of BK polyomavirus spread in European populations. J. Gen. Virol., November 1, 2006; 87(Pt 11): 3201 - 3208. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Shackelton, A. Rambaut, O. G. Pybus, and E. C. Holmes JC Virus Evolution and Its Association with Human Populations. J. Virol., October 1, 2006; 80(20): 9928 - 9933. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Sharma, G. Gupta, A. Vats, R. Shapiro, and P. Randhawa Phylogenetic Analysis of Polyomavirus BK Sequences. J. Virol., September 1, 2006; 80(18): 8869 - 8879. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, J. Trofe, J. Gordon, R. A. Du Pasquier, P. Roy-Chaudhury, M. J. Kuroda, E. S. Woodle, K. Khalili, and I. J. Koralnik Interplay of Cellular and Humoral Immune Responses against BK Virus in Kidney Transplant Recipients with Polyomavirus Nephropathy. J. Virol., April 1, 2006; 80(7): 3495 - 3505. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takasaka, N. Goya, H. Ishida, K. Tanabe, H. Toma, T. Fujioka, S. Omori, H.-Y. Zheng, Q. Chen, S. Nukuzuma, et al. Stability of the BK polyomavirus genome in renal-transplant patients without nephropathy J. Gen. Virol., February 1, 2006; 87(2): 303 - 306. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |